ICD-10-CM Billable Code

L44.0

Pityriasis rubra pilaris

Clinical Classification Guidelines

Medical Intelligence & Overview

Pityriasis rubra pilaris (PRP) is a rare skin condition characterized by scaling, redness, and thickened patches of skin. It affects both children and adults, leading to widespread skin changes that can be challenging to manage. Although its exact cause remains unknown, PRP shares similarities with psoriasis and can sometimes be mistaken for other skin disorders. Recognizing its signs early helps in managing symptoms and improving quality of life.

Causes & Symptoms

Clinical Causes: The precise cause of PRP is unknown. It may have a genetic component, as some cases tend to run in families. PRP can sometimes develop following infections, vaccinations, or injuries, suggesting an immune system response. Certain medications or environmental factors might trigger or worsen the condition.

Key Symptoms: Red, orange, or brownish thick patches and plaques on the skin. Scaling and roughness on the surface of affected areas. Follicular hyperkeratosis, which appears as small, rough bumps around hair follicles. Widespread redness and skin inflammation. Nail changes, such as thickening or ridging of the nails. In some cases, palmoplantar keratoderma—thickening of the palms and soles. Itching and discomfort may also be present.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of PRP is primarily clinical, based on the appearance of the skin and medical history. Dermatologists may perform a skin biopsy to rule out other skin disorders like psoriasis or eczema. Blood tests are usually not definitive but can help exclude infections or other underlying conditions. Early diagnosis is essential for appropriate management and symptom relief.

Treatment Protocols: While there's no universal cure for PRP, various treatment options aim to control symptoms and reduce flare-ups. These include: - **Topical therapies:** Steroid creams, keratolytics, and moisturizers to reduce inflammation and scale. - **Phototherapy:** Controlled exposure to ultraviolet light may help improve skin lesions. - **Systemic medications:** For extensive or severe cases, doctors may prescribe retinoids, immunosuppressants, or biologic agents to slow disease progression. - **Supportive care:** Regular skin hydration, avoidance of irritants, and managing secondary infections are vital components of care.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is L44.0 a billable ICD-10 code?
Yes, L44.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report L44.0?
Clinical documentation must specify the nature of Pityriasis rubra pilaris and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

pityriasis rubra pilaris